Literature DB >> 9583279

Proliferative activity, p53 expression and loss of heterozygosity on 3p, 9p and 17p in atypical adenomatous hyperplasia of the lung.

S Kitaguchi1, Y Takeshima, T Nishisaka, K Inai.   

Abstract

We examined the preneoplastic nature of atypical adenomatous hyperplasia (AAH) of the lung by comparing the proliferative activity, p53 oncosuppressor gene product and loss of heterozygosity (LOH) on 3p, 9p and 17p of 20 AAH lesions (8 cases) with corresponding normal peripheral lung tissue and adenocarcinoma from the same cases. Analysis of proliferative activity with the Ki-67 labelling index and argyrophilic nucleolar organizer regions (AgNORs) score indicated that AAH had a proliferative activity intermediate between that of normal cell and adenocarcinoma. Although low level expression of p53 was detected in 7 AAH lesions, the intensity of p53 expression in AAH was weaker than that in carcinomas. Microsatellite analysis of chromosome 3p, 9p and 17p showed LOH of 18%, 13% and 6% respectively in the AAH lesions, while the corresponding carcinomatous lesions showed LOH of 67%, 50% and 17% respectively. All AAH lesions that showed LOH had moderate or severe histological atypia. One AAH lesion with moderate atypia showed LOH both on 3p and 17p. In conclusion, these results indicated that AAH lesions with moderate or severe atypia may show the preneoplastic stage of lung adenocarcinoma.

Entities:  

Mesh:

Year:  1998        PMID: 9583279

Source DB:  PubMed          Journal:  Hiroshima J Med Sci        ISSN: 0018-2052


  7 in total

1.  Targeted next-generation sequencing for analyzing the genetic alterations in atypical adenomatous hyperplasia and adenocarcinoma in situ.

Authors:  Xuan Xu; Na Li; Ruiying Zhao; Lei Zhu; Jinchen Shao; Jie Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2017-08-18       Impact factor: 4.553

2.  Loss of heterozygosity on chromosomes 9q and 16p in atypical adenomatous hyperplasia concomitant with adenocarcinoma of the lung.

Authors:  K Takamochi; T Ogura; K Suzuki; H Kawasaki; Y Kurashima; T Yokose; A Ochiai; K Nagai; Y Nishiwaki; H Esumi
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

3.  MCM2--a promising marker for premalignant lesions of the lung: a cohort study.

Authors:  D F Tan; J A Huberman; A Hyland; G M Loewen; J S Brooks; A F Beck; I T Todorov; G Bepler
Journal:  BMC Cancer       Date:  2001-06-25       Impact factor: 4.430

Review 4.  Early glandular neoplasia of the lung.

Authors:  W H Westra
Journal:  Respir Res       Date:  2000-11-17

5.  Genomic landscape of allelic imbalance in premalignant atypical adenomatous hyperplasias of the lung.

Authors:  Smruthy Sivakumar; F Anthony San Lucas; Yasminka A Jakubek; Tina L McDowell; Wenhua Lang; Noah Kallsen; Shanna Peyton; Gareth E Davies; Junya Fukuoka; Yasushi Yatabe; Jianjun Zhang; P Andrew Futreal; Jerry Fowler; Junya Fujimoto; Erik A Ehli; Ernest T Hawk; Ignacio I Wistuba; Humam Kadara; Paul Scheet
Journal:  EBioMedicine       Date:  2019-03-21       Impact factor: 8.143

Review 6.  Rationale for Lung Adenocarcinoma Prevention and Drug Development Based on Molecular Biology During Carcinogenesis.

Authors:  Hongming Zhang; Liting Guo; Jibei Chen
Journal:  Onco Targets Ther       Date:  2020-04-14       Impact factor: 4.147

7.  Lung cancer in which the hypothesis of multi-step progression is confirmed by array-CGH results: A case report.

Authors:  Daniela Bettio; Anna Venci; Valentina Achille; Marco Alloisio; Armando Santoro
Journal:  Exp Ther Med       Date:  2015-11-16       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.